Q4 2010

Filed Mar 30, 2011 · 10-K · 89 days after period end · 0001193125-11-082222

Q4 2010 · 10-K

derived · Computed from the longer spans the company filed.

Revenue—

Net income—

EPS, diluted—Not derived. Share counts vary by quarter.

Operating Cash Flowderived-$1,771,858—

Free Cash Flowderived-$1,680,561

Same quarter

no prior Q4 2009 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

ended Dec 31, 2010 · filed Mar 30, 2011 · 89 d after period end

Oragenics Inc · CIK 1174940 · Engraved from SEC EDGAR